Skip to main content
. 2021 Jul 1;2021:8825091. doi: 10.1155/2021/8825091

Table 1.

Participant demographic variables.

Controls (n = 146) Tic disorders group (n = 64) Tics without comorbid ADHD (n = 33) Tics with comorbid ADHD (n = 31)
Mean age (standard deviation) 12.99 (4.10) 12.38 (2.58) 12.53 (2.70) 12.38 (2.51)
Left-hand dominant (percent of total) 13/146 (8.9%) 11/64 (17.19%) 3/33 (9.09%) 8/31 (25.81%)
Male : female ratio (percent male of total) 77 : 69 (52.74%) 60 : 4 (93.75%) 28 : 5 (84.85%) 30 : 1 (96.77%)

Comorbidities in tic disorders group
Attention-deficit hyperactivity disorder 31/64 (48%)
Obsessive-compulsive disorder 16/64 (25%) 6/33 (18.18%) 10/31 (32.26%)
Generalized anxiety disorder 16/64 (25%) 8/33 (24.24%) 8/31 (25.81%)
Depression 5/64 (7.8%) 3/33 (9.09%) 2/31 (6.45%)
Autism spectrum disorder 5/64 (7.8%) 1/33 (3.03%) 4/31 (12.9%)

Medications for tics in tic disorders group (number of participants and percentage of group)
Aripiprazole 5 (7.81%)
Clonidine 4 (6.25%)
Guanfacine 4 (6.25%)
Risperidone 1 (1.56%)
Topiramate 1 (1.56%)
No medications for tics 49 (76.56%)